These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3969034)

  • 21. Phase I evaluation of vindesine in children: a Southwest Oncology Group pilot study.
    Komp D; Vats T; Shepherd DA; Vietti T; Hoogstraten B; Haas CD
    Med Pediatr Oncol; 1980; 8(3):243-50. PubMed ID: 7193278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of vindesine in patients with malignant lymphoma.
    Sklaroff RB; Straus D; Young C
    Cancer Treat Rep; 1979 May; 63(5):793-4. PubMed ID: 455317
    [No Abstract]   [Full Text] [Related]  

  • 23. Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study.
    DiBella NJ; Berris R; Garfield D; Fink K; Speer J; Sakamoto A
    Invest New Drugs; 1984; 2(3):323-8. PubMed ID: 6511238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors.
    Miller TP; Jones SE; Chester A
    Cancer Treat Rep; 1980; 64(8-9):1001-3. PubMed ID: 7448818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of vindesine in patients with Hodgkin's disease, lymphoma, and breast cancer.
    Gad-El-Mawla N; Hamza MR; El-Serafi M; El-Khoudary A; Aboul-Einein M; El-Demerdash S
    Cancer Treat Rep; 1983 Mar; 67(3):316-7. PubMed ID: 6831481
    [No Abstract]   [Full Text] [Related]  

  • 26. An EORTC phase II study of vindesine in advanced prostate cancer.
    Jones WG; Fosså SD; Denis L; Coninx P; Glashan RW; Akdas A; De Pauw M
    Eur J Cancer Clin Oncol; 1983 May; 19(5):583-8. PubMed ID: 6683629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II trial of vindesine in breast cancer, lymphoma and other tumors: future directions.
    Miller TP; Jones SE; Chester AB; Dorr RT
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():81-6. PubMed ID: 7438127
    [No Abstract]   [Full Text] [Related]  

  • 28. A phase II study of vindesine in patients with hematological malignancies.
    Hulhoven R; Michaux JL; Cornu G; Ferránt A; Bosly A; Delannoy A; Sokal G
    Biomedicine; 1980 Apr; 33(2):31-2. PubMed ID: 6931617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vinca-23-oyl amino acid derivatives: as new anticancer agents (review).
    Bhushana Rao KS; Collard MP; Trouet A
    Anticancer Res; 1985; 5(4):379-86. PubMed ID: 3898995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vindesine. A phase II trial in advanced breast cancer patients.
    Robins HI; Tormey DC; Skelley MJ; Falkson G; Crowley JJ; Ramirez G; Falkson H
    Cancer Clin Trials; 1981; 4(4):371-5. PubMed ID: 7318120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Salvage chemotherapy in resistant malignant lymphomas (author's transl)].
    Tursz T; Ben Ayed F; Droz JP; Spielmann M; Amiel JL
    Bull Cancer; 1982; 69(1):28-32. PubMed ID: 6176284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
    Vats T; Buchanan G; Mehta P; Ragab A; Hvizdale E; Nitschke R; Link M; Beardsley GP; Maybee D; Krischer J
    Invest New Drugs; 1992 Aug; 10(3):231-4. PubMed ID: 1428733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
    Straus DJ; Myers J; Koziner B; Lee BJ; Clarkson BD
    Cancer Chemother Pharmacol; 1983; 11(2):80-5. PubMed ID: 6194913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vindesine, a new cytostatic agent from the vinca alkaloids].
    Goldhirsch A; Joss R; Sonntag RW; Brunner KW
    Dtsch Med Wochenschr; 1980 Jun; 105(26):931-5. PubMed ID: 6931709
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase II clinical trial with vindesine for remission induction in acute leukemia, blastic crisis of chronic myeloid leukemia, lymphosarcoma, and hodgkin's disease: absence of cross-resistance with vincristine.
    Mathé G; Misset JL; De Vassal F; Gouveia J; Hayat M; Machover D; Belpomme D; Pico JL; Schwarzenberg L; Ribaud P; Musset M; Jasmin C; De Luca L
    Cancer Treat Rep; 1978 May; 62(5):805-9. PubMed ID: 274996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vindesine. A review of phase-II trials.
    Gralla RJ; Tan CT; Young CW
    Cancer Chemother Pharmacol; 1979; 2(4):271-4. PubMed ID: 455587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A presumed transient hemolytic reaction following vinca alkaloids administration in patients with hematological malignancies].
    Iwata N; Wakamatsu E; Oike S; Umegae S; Omine M; Maekawa T; Tsuchiya J
    Rinsho Ketsueki; 1984 May; 25(5):649-54. PubMed ID: 6590896
    [No Abstract]   [Full Text] [Related]  

  • 39. Vindesine in the treatment of malignant mesothelioma: a phase II study.
    Kelsen D; Gralla R; Cheng E; Martini N
    Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of advanced breast cancer with mitomycin C combined with vinblastine or vindesine.
    Garewal HS; Brooks RJ; Jones SE; Miller TP
    J Clin Oncol; 1983 Dec; 1(12):772-5. PubMed ID: 6422004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.